{"id":"a3","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Cough"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":null,"_dailymed":{"setId":"4baa5c95-79a6-4ae8-a8c4-1edbf308f92c","title":"VIREX (ADENOVIREN NOSODE, ASCLEPIAS TUBEROSA, CALCAREA ARSENICICA, CAMPHORA, COXSACKIE A2 NOSODE, COXSACKIE A3 NOSODE, COXSACKIE A4 NOSODE, COXSACKIE A5 NOSODE, COXSACKIE A7 NOSODE, COXSACKIE B1 NOSODE, COXSACKIE B3 NOSODE, COXSACKIE B4 NOSODE, COXSACKIE B5 NOSODE, CYTOMEGALOVIRUS NOSODE, ECHINACEA PURPUREA, EPSTEIN-BARR VIRUS NOSODE, EUPHRASIA OFFICINALIS, INFLUENZINUM, LAC VACCINUM, MORBILLINUM, NATRUM MURIATICUM, PHYTOLACCA DECANDRA, THUJA OCCIDENTALIS, TRIFOLIUM PRATENSE, VARIOLINUM) SPRAY [NUTRITIONAL SPECIALTIES, INC.]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"A3 is an angiotensin receptor blocker (ARB) that blocks the action of angiotensin II, a potent vasoconstrictor, thereby reducing blood pressure and decreasing the workload on the heart.","oneSentence":"A3 is a medication that works by inhibiting the renin-angiotensin system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:51:18.263Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Heart failure"}]},"trialDetails":[{"nctId":"NCT04275999","phase":"PHASE2","title":"Rosacea and Ivermectin","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2021-04-16","conditions":"Rosacea","enrollment":30},{"nctId":"NCT04774237","phase":"PHASE2","title":"Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia","status":"COMPLETED","sponsor":"Visus Therapeutics","startDate":"2021-03-24","conditions":"Presbyopia","enrollment":18},{"nctId":"NCT07157982","phase":"NA","title":"Living With Multimorbidity: Care Coordination and Symptom Management Program (COORDINATE)","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-05","conditions":"Multimorbidity","enrollment":10},{"nctId":"NCT07496008","phase":"","title":"Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population","status":"NOT_YET_RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2026-03-25","conditions":"Isavuconazole, Invasion Pulmonary Mycosis","enrollment":150},{"nctId":"NCT05564377","phase":"PHASE2","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-04-07","conditions":"Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8","enrollment":2900},{"nctId":"NCT07497503","phase":"PHASE1","title":"A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants","status":"NOT_YET_RECRUITING","sponsor":"Syneos Health","startDate":"2026-04-10","conditions":"Healthy Volunteers","enrollment":48},{"nctId":"NCT07316985","phase":"","title":"Efficacy of Physical Fitness Training Combined With Exercise Therapy on Gait in Children With Cerebral Palsy","status":"COMPLETED","sponsor":"LiNa Zhang","startDate":"2023-06-01","conditions":"Spastic Cerebral Palsy","enrollment":72},{"nctId":"NCT04785820","phase":"PHASE2","title":"A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2021-06-25","conditions":"Advanced or Metastatic Esophageal Squamous Cell Carcinoma","enrollment":190},{"nctId":"NCT05840159","phase":"PHASE4","title":"A Study of Doxycycline to Treat Chlamydial Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-01-19","conditions":"Chlamydial Infection","enrollment":526},{"nctId":"NCT07496554","phase":"NA","title":"Long-term Effects of Early Shoulder Exercise After CIED Implantation","status":"COMPLETED","sponsor":"Erzincan Binali Yildirim Universitesi","startDate":"2021-02-01","conditions":"Cardiac Implantable Electronic Device (CIED), Shoulder Dysfunction","enrollment":89},{"nctId":"NCT00410241","phase":"","title":"ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2007-01-05","conditions":"Healthy Volunteers, Atherosclerotic Heart Disease","enrollment":1665},{"nctId":"NCT00001168","phase":"","title":"Evaluation of Lipoproteins","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1979-01-01","conditions":"Evaluation of Plasma Lipoproteins","enrollment":1017},{"nctId":"NCT04633252","phase":"PHASE1, PHASE2","title":"A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-02-23","conditions":"Cancer Of Prostate, Prostate Neoplasms","enrollment":86},{"nctId":"NCT07290283","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-12-10","conditions":"Healthy Participants","enrollment":176},{"nctId":"NCT06627582","phase":"NA","title":"A Study on Pain After Breast Reconstruction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2024-10-01","conditions":"Mastectomy, Mastectomy Patient, Mastectomy and Breast Reconstruction","enrollment":274},{"nctId":"NCT05210374","phase":"PHASE1","title":"Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2023-03-09","conditions":"Relapsed Sarcomas","enrollment":24},{"nctId":"NCT04127994","phase":"NA","title":"Glycemic Variability Comparing Two vs Five Meals in Type 2 Diabetes","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2018-08-17","conditions":"Diabetes Mellitus Type 2, Overweight and Obesity, Meal Time","enrollment":50},{"nctId":"NCT05651919","phase":"","title":"PBMC as Biomarkers of Diabetic Cardiomyopathy","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2023-05-23","conditions":"Type 2 Diabetes, Metabolic Syndrome, Heart Failure With Preserved Ejection Fraction","enrollment":175},{"nctId":"NCT05184816","phase":"PHASE1","title":"A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-12-22","conditions":"Leptomeningeal Metastases","enrollment":35},{"nctId":"NCT06637371","phase":"PHASE1","title":"A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma","status":"RECRUITING","sponsor":"Amgen","startDate":"2024-10-16","conditions":"Asthma","enrollment":124},{"nctId":"NCT06991738","phase":"PHASE1, PHASE2","title":"177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2026-04-01","conditions":"Thyroid Cancer","enrollment":18},{"nctId":"NCT06554665","phase":"NA","title":"Powering Up Stroke Rehabilitation Through HIIT","status":"RECRUITING","sponsor":"The Hong Kong Polytechnic University","startDate":"2024-08-20","conditions":"Stroke","enrollment":66},{"nctId":"NCT07494760","phase":"NA","title":"A Feasibility Randomised Control Trial to Evaluate Early Perinatal Bereavement Counselling for Parents Who Have Experienced a Perinatal Death","status":"NOT_YET_RECRUITING","sponsor":"University of Manchester","startDate":"2026-03-01","conditions":"Stillbirth, Perinatal Death, Psychological","enrollment":26},{"nctId":"NCT07498608","phase":"NA","title":"Effects of Polarized and Threshold Intensity Distribution Models on Race Time and Body Composition in Recreational Runners Aged 20-45 Years.","status":"ENROLLING_BY_INVITATION","sponsor":"Universidad Pedagogica Nacional, Colombia","startDate":"2026-03-16","conditions":"Physical Activity, Physical Activity Intensity, Physical Activity in Adults","enrollment":20},{"nctId":"NCT07493044","phase":"PHASE1","title":"An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"Guangzhou FineImmune Biotechnology Co., LTD.","startDate":"2026-03-20","conditions":"Advanced Hepatocellular Carcinoma (HCC), GPC3 Positive Hepatocellular Carcinoma","enrollment":15},{"nctId":"NCT07217574","phase":"","title":"Program in Oncology for Tribal Health Systems.","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2026-02-11","conditions":"Patient Outcomes","enrollment":187},{"nctId":"NCT07491913","phase":"NA","title":"Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission","status":"RECRUITING","sponsor":"Marmara University","startDate":"2025-06-15","conditions":"Takayasu Arteritis","enrollment":40},{"nctId":"NCT07130357","phase":"NA","title":"The Effect of Collagen Scaffold Augmentation in Achilles Tendon Rupture Repair","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-12-25","conditions":"Achilles Tendon Rupture","enrollment":48},{"nctId":"NCT06745908","phase":"PHASE3","title":"ResQ201A: Clinical Trial Of N-803 Plus TISLELIZUMAB And DOCETAXEL Versus DOCETAXEL Monotherapy In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2025-10-01","conditions":"NSCLC Stage IV","enrollment":460},{"nctId":"NCT06925724","phase":"PHASE2","title":"A Study of Ivonescimab in People With Endometrial and Cervical Cancers","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2025-04-04","conditions":"Endometrial Cancer, Cervical Cancer","enrollment":50},{"nctId":"NCT06834035","phase":"PHASE1, PHASE2","title":"Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa","status":"RECRUITING","sponsor":"M. Peter Marinkovich","startDate":"2025-08-04","conditions":"Epidermolysis Bullosa, Epidermolysis Bullosa Acquisita, Dystrophic Epidermolysis Bullosa","enrollment":8},{"nctId":"NCT07171203","phase":"PHASE1","title":"Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2026-06","conditions":"Gastrointestinal Stromal Tumors","enrollment":18},{"nctId":"NCT07491718","phase":"NA","title":"Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2025-08-08","conditions":"Takotsubo Cardiomyopathy","enrollment":100},{"nctId":"NCT07380490","phase":"NA","title":"Comparing Two PFO Closure Devices in Adults With Previous Stroke or TIA","status":"NOT_YET_RECRUITING","sponsor":"Giuseppe Tarantini","startDate":"2026-04","conditions":"Patent Foramen Ovale, Stroke, Transient Ischemic Attack (TIA)","enrollment":1260},{"nctId":"NCT07490691","phase":"NA","title":"Painhunting Therapy for Interpersonal Loss-Related Depression","status":"NOT_YET_RECRUITING","sponsor":"Painhunting LLP","startDate":"2026-03-23","conditions":"Loss-Related Depression, Interpersonal Loss, Complicated Grief","enrollment":72},{"nctId":"NCT06353386","phase":"PHASE1, PHASE2","title":"Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-05-20","conditions":"Prostatic Neoplasms, Castration-Resistant","enrollment":220},{"nctId":"NCT07491822","phase":"NA","title":"A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2026-03-25","conditions":"TNBC","enrollment":43},{"nctId":"NCT07126158","phase":"PHASE2","title":"Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-04-30","conditions":"Pancreatic Adenocarcinoma, Cancer of the Pancreas, Pancreas Cancer","enrollment":36},{"nctId":"NCT06094816","phase":"PHASE4","title":"Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study","status":"RECRUITING","sponsor":"University of Delaware","startDate":"2024-03-05","conditions":"Salt-Sensitivity of Blood Pressure","enrollment":120},{"nctId":"NCT06862453","phase":"PHASE1","title":"Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults","status":"NOT_YET_RECRUITING","sponsor":"Sanaria Inc.","startDate":"2026-03","conditions":"Malaria Falciparum","enrollment":58},{"nctId":"NCT07488533","phase":"PHASE2","title":"Comparing the Combination of Sullumab and Fruquintinib in Postoperative Adjuvant Therapy for High Recurrence Risk Non Transparent Renal Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-08-01","conditions":"Non-Clear Cell Renal Cell Carcinoma","enrollment":40},{"nctId":"NCT07488065","phase":"PHASE1","title":"A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.","startDate":"2026-03-25","conditions":"Atopic Dermatitis","enrollment":90},{"nctId":"NCT06667141","phase":"PHASE1","title":"Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors","status":"RECRUITING","sponsor":"Acrivon Therapeutics","startDate":"2024-10-08","conditions":"Specific Advanced Solid Tumors","enrollment":100},{"nctId":"NCT06003504","phase":"NA","title":"The Impact of First Aid Blended Learning Training on Learning Outcomes and Helping Behaviour of Adult Laypeople in Rwanda","status":"COMPLETED","sponsor":"Centre for Evidence-Based Practice, Belgium","startDate":"2023-07-13","conditions":"Emergencies, Injuries, Illness Physical","enrollment":540},{"nctId":"NCT07487740","phase":"PHASE1","title":"A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants","status":"RECRUITING","sponsor":"Trevi Therapeutics","startDate":"2026-02-27","conditions":"Healthy Participants","enrollment":60},{"nctId":"NCT07488546","phase":"PHASE1, PHASE2","title":"HCL001 Cell Injection for Decompensated Cirrhosis: A Phase I/II Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Shanghai Huicun Medical Technology Co., Ltd.","startDate":"2025-09-23","conditions":"Decompensated Cirrhosis","enrollment":39},{"nctId":"NCT07355868","phase":"EARLY_PHASE1","title":"Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy","status":"RECRUITING","sponsor":"Regend Therapeutics","startDate":"2026-03-19","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":12},{"nctId":"NCT04998669","phase":"PHASE2","title":"Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma","status":"RECRUITING","sponsor":"Juan P. Alderuccio, MD","startDate":"2022-02-11","conditions":"Follicular Lymphoma","enrollment":100},{"nctId":"NCT07235059","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-11-20","conditions":"Chronic Kidney Disease","enrollment":112},{"nctId":"NCT07484477","phase":"NA","title":"Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients.","status":"NOT_YET_RECRUITING","sponsor":"Riphah International University","startDate":"2026-03-30","conditions":"Post-cardiac Surgery Patients","enrollment":24},{"nctId":"NCT07024823","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-06-09","conditions":"Chronic Kidney Disease","enrollment":124},{"nctId":"NCT00720785","phase":"PHASE1","title":"Natural Killer Cells and Bortezomib to Treat Cancer","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2008-08-01","conditions":"Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca","enrollment":35},{"nctId":"NCT07485712","phase":"NA","title":"Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2","status":"NOT_YET_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2026-08-31","conditions":"Mild Cognitive Impairment","enrollment":290},{"nctId":"NCT07326709","phase":"PHASE3","title":"A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-06-01","conditions":"Huntington Disease","enrollment":770},{"nctId":"NCT06994897","phase":"PHASE1","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-08-13","conditions":"Healthy","enrollment":92},{"nctId":"NCT05235061","phase":"NA","title":"HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) -Post-Traumatic Epilepsy (PTE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2022-03-21","conditions":"Epilepsy, Traumatic, Brain Injuries, Traumatic","enrollment":160},{"nctId":"NCT05168982","phase":"","title":"Development of Non-Invasive MRI Applications for Liver Fibrosis and Inflammation","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2021-08-01","conditions":"Liver Fibrosis","enrollment":200},{"nctId":"NCT07482254","phase":"NA","title":"Acute Effects of Isometric Conditioning on Sprint, Jump and Change of Direction Performance in Youth Soccer Players","status":"ENROLLING_BY_INVITATION","sponsor":"The Jerzy Kukuczka Academy of Physical Education in Katowice","startDate":"2026-03-10","conditions":"Athletic Performance, Soccer, Isometric Strength Training","enrollment":12},{"nctId":"NCT04881838","phase":"PHASE3","title":"CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2021-03-01","conditions":"Pediatric Anaplastic Large Cell Lymphoma","enrollment":172},{"nctId":"NCT06189391","phase":"PHASE1","title":"A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)","status":"RECRUITING","sponsor":"MSD R&D (China) Co., Ltd.","startDate":"2021-03-16","conditions":"Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma","enrollment":100},{"nctId":"NCT06406114","phase":"PHASE2","title":"Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-05-05","conditions":"Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity","enrollment":300},{"nctId":"NCT07235150","phase":"PHASE1","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-12-11","conditions":"Healthy","enrollment":76},{"nctId":"NCT07277582","phase":"PHASE2, PHASE3","title":"Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)","status":"RECRUITING","sponsor":"Thryv Therapeutics, Inc.","startDate":"2026-03-31","conditions":"Long QT Syndrome (LQTS) 2","enrollment":64},{"nctId":"NCT06995820","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-06-06","conditions":"Healthy","enrollment":136},{"nctId":"NCT07392372","phase":"PHASE1","title":"A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2026-02-09","conditions":"HIV -1 Infection","enrollment":61},{"nctId":"NCT04192344","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor","status":"RECRUITING","sponsor":"Abbisko Therapeutics Co, Ltd","startDate":"2020-01-20","conditions":"Neoplasms, Tenosynovial Giant Cell Tumor","enrollment":276},{"nctId":"NCT07294729","phase":"NA","title":"Mulligan and Proprioceptive Neuromuscular Facilitation Techniques in Individuals With Rotator Cuff Lesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medipol University","startDate":"2025-12-25","conditions":"Rotator Cuff Syndrome, Rotator Cuff Injuries","enrollment":45},{"nctId":"NCT07479498","phase":"NA","title":"Mountain West Prevention Research Center Core Research Project","status":"RECRUITING","sponsor":"Paul Estabrooks","startDate":"2024-09-30","conditions":"Childhood Obesity","enrollment":600},{"nctId":"NCT07102875","phase":"NA","title":"Ready to Sail 2: A Pilot Study of Sail-Assisted Telerehabilitation in Rare Skeletal Diseases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2025-07-15","conditions":"Rare Bone Disorders","enrollment":24},{"nctId":"NCT07479459","phase":"NA","title":"Different Education Methods and Self Vulvar Examination (SVE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yeditepe University","startDate":"2023-01-15","conditions":"Vulvar Self-Examination, Health Knowledge,Practices,Attitudes, Vulva Disease","enrollment":105},{"nctId":"NCT04657068","phase":"PHASE1, PHASE2","title":"A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Artios Pharma Ltd","startDate":"2021-01-27","conditions":"Advanced Cancer, Metastatic Cancer, Ovarian Cancer","enrollment":442},{"nctId":"NCT07481149","phase":"PHASE3","title":"Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN)","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-03-30","conditions":"Chemotherapy-induced Peripheral Neuropathy (CIPN)","enrollment":240},{"nctId":"NCT07479134","phase":"NA","title":"Production of Stem Cells for the Generation of Pancreatic Cells","status":"RECRUITING","sponsor":"Ospedale San Raffaele","startDate":"2026-03-01","conditions":"Diabetes","enrollment":100},{"nctId":"NCT06618599","phase":"NA","title":"Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-10-01","conditions":"Lung Cancer","enrollment":60},{"nctId":"NCT05300139","phase":"","title":"Ancillary Study of the ULTREC Project","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2021-11-29","conditions":"Deep Vein Thrombosis","enrollment":18},{"nctId":"NCT07476014","phase":"EARLY_PHASE1","title":"Early Clinical Study on the Use of Donor-derived EBV-specific T Cells for the Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-02-28","conditions":"Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation","enrollment":18},{"nctId":"NCT06671587","phase":"PHASE4","title":"iGlarLixi CGM Study in Chinese T2D Individuals After OADs","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-12-10","conditions":"Type 2 Diabetes (T2D)","enrollment":678},{"nctId":"NCT06879041","phase":"PHASE1","title":"A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-10","conditions":"Metastatic Castration-Resistant Prostate Cancer","enrollment":95},{"nctId":"NCT07435701","phase":"PHASE1, PHASE2","title":"Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2026-01-05","conditions":"Ovarian Neoplasms Malignant, Ascites","enrollment":29},{"nctId":"NCT07478484","phase":"PHASE4","title":"Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB","status":"RECRUITING","sponsor":"Jing Zhou","startDate":"2026-03-31","conditions":"Ceftazidime-avibactam, Aztreonam, Gram-negative Bacterial Infection","enrollment":144},{"nctId":"NCT05393258","phase":"NA","title":"Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2022-06-28","conditions":"Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant","enrollment":13},{"nctId":"NCT04042935","phase":"PHASE1","title":"Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-02-27","conditions":"HNSCC","enrollment":5},{"nctId":"NCT04246437","phase":"PHASE1","title":"[18F]F-DOPA Imaging in Patients With Autonomic Failure","status":"RECRUITING","sponsor":"Daniel Claassen","startDate":"2020-02-04","conditions":"Autonomic Failure, Pure Autonomic Failure, Parkinson Disease","enrollment":40},{"nctId":"NCT07466940","phase":"PHASE1","title":"A Clinical Study to Evaluate SM17 in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"SinoMab BioScience Ltd","startDate":"2025-10-14","conditions":"Atopic Dermatitis, Asthma, Inflammatory Bowel Disease","enrollment":30},{"nctId":"NCT07475481","phase":"NA","title":"Exercise-Based Strategies for Chronic Back Pain","status":"NOT_YET_RECRUITING","sponsor":"Charles University, Czech Republic","startDate":"2027-07-01","conditions":"Chronic Low-back Pain (cLBP)","enrollment":120},{"nctId":"NCT07465315","phase":"PHASE2, PHASE3","title":"Behavioural Intervention to Decrease Exposure to Emerging Chemical Pollutants","status":"NOT_YET_RECRUITING","sponsor":"Universidad de Granada","startDate":"2026-05","conditions":"Environmental Exposure","enrollment":740},{"nctId":"NCT03842982","phase":"PHASE3","title":"Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2019-05-03","conditions":"Ovary Neoplasms, Ovarian Cancer, Ovarian Carcinoma","enrollment":362},{"nctId":"NCT07387354","phase":"PHASE1, PHASE2","title":"Pacritinib With Aza for Upfront Myelodysplastic Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2026-05","conditions":"Myelodysplastic Syndromes, MDS, Myelodysplastic Syndrome, Unclassifiable","enrollment":25},{"nctId":"NCT06691880","phase":"NA","title":"Feasibility of Video Gaming Technology for Arm Recovery Early Post-stroke","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2020-03-12","conditions":"Subacute Stroke, Acute Stroke","enrollment":58},{"nctId":"NCT07292922","phase":"NA","title":"Digital-supported Orofacial Myofunctional Therapy in OSA","status":"RECRUITING","sponsor":"Hong Kong Metropolitan University","startDate":"2026-01-05","conditions":"Obstructive Sleep Apnea (OSA)","enrollment":60},{"nctId":"NCT06485245","phase":"PHASE1","title":"Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cascade Pharmaceuticals, Inc","startDate":"2025-04-22","conditions":"MASH","enrollment":80},{"nctId":"NCT05735184","phase":"PHASE1","title":"A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML","status":"RECRUITING","sponsor":"Kura Oncology, Inc.","startDate":"2023-07-18","conditions":"Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation, Refractory AML","enrollment":420},{"nctId":"NCT04557059","phase":"PHASE3","title":"A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Pharmaceutica N.V., Belgium","startDate":"2020-11-12","conditions":"Prostatic Neoplasms","enrollment":693},{"nctId":"NCT04468659","phase":"PHASE3","title":"AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eisai Inc.","startDate":"2020-07-14","conditions":"Preclinical Alzheimer's Disease, Early Preclinical Alzheimer's Disease","enrollment":1400},{"nctId":"NCT07469631","phase":"NA","title":"Brain Networks Involved in Inner World Control","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2026-05-01","conditions":"Neurosciences","enrollment":60},{"nctId":"NCT05921201","phase":"NA","title":"Preventing Depression of Chinese American Adolescents by RRE","status":"RECRUITING","sponsor":"Northeastern University","startDate":"2024-03-25","conditions":"Subclinical Depressive Symptoms","enrollment":110},{"nctId":"NCT05827016","phase":"PHASE3","title":"A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2023-06-22","conditions":"Multiple Myeloma","enrollment":1216},{"nctId":"NCT04105114","phase":"EARLY_PHASE1","title":"Transformation of Paralysis to Stepping","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Louisville","startDate":"2019-09-30","conditions":"Spinal Cord Injuries","enrollment":15},{"nctId":"NCT07069179","phase":"NA","title":"Feasibility of Choose to Move Replacement Ready","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-07-14","conditions":"Osteoarthritis, Osteoarthritis (OA) of the Knee, Osteoarthritis, Hip","enrollment":60},{"nctId":"NCT06382207","phase":"NA","title":"Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs","status":"RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2025-01-17","conditions":"Tachyarrhythmia","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":24027,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Equatir 10 T10/C10 - CBD 10%, THC 10%"],"phase":"marketed","status":"active","brandName":"A3","genericName":"A3","companyName":"Breath of Life International Pharma Ltd","companyId":"breath-of-life-international-pharma-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A3 is a medication that works by inhibiting the renin-angiotensin system. Used for Hypertension, Heart failure.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}